The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice
Open accessAbstract
Wnt signaling increases bone mass by stimulating osteoblast lineage commitment and expansion and forms the basis for novel anabolic therapeutic strategies being developed for osteoporosis. These strategies include derepression of Wnt signaling by targeting secreted Wnt pathway antagonists, such as sclerostin. However, such therapies are associated with safety concerns regarding an increased risk of osteosarcoma, the most common primary malignancy of bone. Here, we analyzed 5 human osteosarcoma cell lines in a high-throughput screen for epigenetically silenced tumor suppressor genes and identified Wnt inhibitory factor 1 (WIF1), which encodes an endogenous secreted Wnt pathway antagonist, as a candidate tumor suppressor gene. In vitro, WIF1 suppressed beta-catenin levels in human osteosarcoma cell lines, induced differentiation of human and mouse primary osteoblasts, and suppressed the growth of mouse and human osteosarcoma cell lines. Wif1 was highly expressed in the developing and mature mouse skeleton, and, although it was dispensable for normal development, targeted deletion of mouse Wif1 accelerated development of radiation-induced osteosarcomas in vivo. In primary human osteosarcomas, silencing of WIF1 by promoter hypermethylation was associated with loss of differentiation, increased beta-catenin levels, and increased proliferation. These data lead us to suggest that derepression of Wnt signaling by targeting secreted Wnt antagonists in osteoblasts may increase susceptibility to osteosarcoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia
Román-Gómez, J., Cordeu, L., Agirre, X., Jiménez-Velasco, A., San José-Eneriz, E., Garate, L., Calasanz, M. J., Heiniger, A., Torres, A., & Prosper, F. (2007) · Blood · doi:10.1182/blood-2006-09-047043 · Cited by 168
RetractedInternational Agency for Research on Cancer
National Cancer Institute (2020) · Definitions · doi:10.32388/pfg7jq · Cited by 9,435
β-Catenin regulates expression of cyclin D1 in colon carcinoma cells
Tetsu, O., & McCormick, F. (1999) · Nature · doi:10.1038/18884 · Cited by 3,601
Yang, Y. H. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.4.e15 · Cited by 3,464
Frommer, M., McDonald, L. E., Millar, D. S., Collis, C. M., Watt, F., Grigg, G. W., Molloy, P. L., & Paul, C. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1827 · Cited by 3,238
Derivation of completely cell culture-derived mice from early-passage embryonic stem cells.
Nagy, A., Rossant, J., Nagy, R., Abramow-Newerly, W., & Roder, J. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8424 · Cited by 2,329
LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development
Gong, Y., Slee, R. B., Fukai, N., Rawadi, G., Roman-Roman, S., Reginato, A. M., Wang, H., Cundy, T., Glorieux, F. H., Lev, D., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00571-2 · Cited by 2,235
Pathology and genetics of tumours of soft tissue and bone
Fletcher, C. D. �., Unni, K. K., & Mertens, F. (2002) · Medical Entomology and Zoology · Cited by 2,073
Improved retroviral vectors for gene transfer and expression.
Miller, A. D., & Rosman, G. J. (1989) · PubMed · Cited by 1,971
DNA hypermethylation in tumorigenesis: epigenetics joins genetics
Baylin, S. B., & Herman, J. G. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(99)01971-x · Cited by 1,628
High Bone Density Due to a Mutation in LDL-Receptor–Related Protein 5
Boyden, L. M., Mao, J., Belsky, J., Mitzner, L., Farhi, A., Mitnick, M. A., Wu, D., Insogna, K., & Lifton, R. P. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013444 · Cited by 1,591
Secreted antagonists of the Wnt signalling pathway
Kawano, Y., & Kypta, R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00623 · Cited by 1,584
Canonical wnt signaling in differentiated osteoblasts controls osteoclast differentiation.
Glass, D. A., Bialek, P., Ahn, J. D., Starbuck, M., Patel, M. S., Clevers, H., Taketo, M. M., Long, F., McMahon, A. P., Lang, R. A., et al. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.02.017 · Cited by 1,558
Simmons, P., & Torok-Storb, B. (1991) · Blood · doi:10.1182/blood.v78.1.55.55 · Cited by 1,176
Self-citationNormal genetically mosaic mice produced from malignant teratocarcinoma cells.
Mintz, B., & Illmensee, K. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3585 · Cited by 1,176
Function and biological roles of the Dickkopf family of Wnt modulators
Niehrs, C. (2006) · Oncogene · doi:10.1038/sj.onc.1210054 · Cited by 995
Stable suppression of tumorigenicity by virus-mediated RNA interference
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00122-8 · Cited by 886
The many ways of Wnt in cancer
Polakis, P. (2007) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2006.12.007 · Cited by 866
Ehrich, M., Nelson, M. R., Stanssens, P., Zabeau, M., Liloglou, T., Xinarianos, G., Cantor, C. R., Field, J. K., & van den Boom, D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507816102 · Cited by 812
Self-citationA new secreted protein that binds to Wnt proteins and inhibits their activites
Hsieh, J.-C., Kodjabachian, L., Rebbert, M. L., Rattner, A., Smallwood, P. M., Samos, C. H., Nusse, R., Dawid, I. B., & Nathans, J. (1999) · Nature · doi:10.1038/18899 · Cited by 750
Self-citationSpl elements protect a CpG island from de novo methylation
Brandeis, M., Frank, D., Keshet, I., Siegfried, Z., Mendelsohn, M., Names, A., Temper, V., Razin, A., & Cedar, H. (1994) · Nature · doi:10.1038/371435a0 · Cited by 706
Mechanisms of Anabolic Therapies for Osteoporosis
Canalis, E., Giustina, A., & Bilezikian, J. P. (2007) · New England Journal of Medicine · doi:10.1056/nejmra067395 · Cited by 668
Bellido, T., Ali, A. A., Gubrij, I., Plotkin, L. I., Fu, Q., O’Brien, C. A., Manolagas, S. C., & Jilka, R. L. (2005) · Endocrinology · doi:10.1210/en.2005-0239 · Cited by 641
Targeting the Wnt/β-Catenin Pathway to Regulate Bone Formation in the Adult Skeleton
Baron, R., & Rawadi, G. (2007) · Endocrinology · doi:10.1210/en.2007-0270 · Cited by 584
Deletion of a Single Allele of the Dkk1 Gene Leads to an Increase in Bone Formation and Bone Mass
Morvan, F., Boulukos, K., Clément-Lacroix, P., Roman, S. R., Suc-Royer, I., Vayssière, B., Ammann, P., Martin, P., Pinho, S., Pognonec, P., et al. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060311 · Cited by 524
Vahle, J. L., Long, G. G., Sandusky, G., Westmore, M., Ma, Y. L., & Sato, M. (2004) · Toxicologic Pathology · doi:10.1080/01926230490462138 · Cited by 376
Reprogramming of a melanoma genome by nuclear transplantation
Hochedlinger, K., Blelloch, R., Brennan, C., Yamada, Y., Kim, M., Chin, L., & Jaenisch, R. (2004) · Genes & Development · doi:10.1101/gad.1213504 · Cited by 367
DNA methylation represses transcription in vivo
Siegfried, Z., Eden, S., Mendelsohn, M., Feng, X., Tsuberi, B.-Z., & Cedar, H. (1999) · Nature Genetics · doi:10.1038/9727 · Cited by 354
Sellers, W. R., Novitch, B. G., Miyake, S., Heith, A., Otterson, G. A., Kaye, F. J., Lassar, A. B., & Kaelin, W. G. (1998) · Genes & Development · doi:10.1101/gad.12.1.95 · Cited by 343
Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation
Li, X., Liu, P., Liu, W., Maye, P., Zhang, J., Zhang, Y., Hurley, M., Guo, C., Boskey, A., Sun, L., et al. (2005) · Nature Genetics · doi:10.1038/ng1614 · Cited by 342
Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer
Aguilera, O., Fraga, M. F., Ballestar, E., Paz, M. F., Herranz, M., Espada, J., García, J. M., Muñoz, A., Esteller, M., & González-Sancho, J. M. (2006) · Oncogene · doi:10.1038/sj.onc.1209439 · Cited by 338
Graff, J. R., Herman, J. G., Myöhänen, S., Baylin, S. B., & Vertino, P. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.22322 · Cited by 319
Gronthos, S., Zannettino, A. C. W., Graves, S. E., Ohta, S., Hay, S. J., & Simmons, P. J. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.1.47 · Cited by 282
Self-citationThe Wnt Antagonist sFRP1 in Colorectal Tumorigenesis
Caldwell, G. M., Jones, C., Gensberg, K., Jan, S., Hardy, R. G., Byrd, P., Chughtai, S., Wallis, Y., Matthews, G. M., & Morton, D. G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1346 · Cited by 281
Molecular Pathogenesis of Osteosarcoma
Kansara, M., & Thomas, D. M. (2007) · DNA and Cell Biology · doi:10.1089/dna.2006.0505 · Cited by 273
Self-citationWnt Inhibitory Factor-1 Is Silenced by Promoter Hypermethylation in Human Lung Cancer
Mazieres, J., He, B., You, L., Xu, Z., Lee, A. Y., Mikami, I., Reguart, N., Rosell, R., McCormick, F., & Jablons, D. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1389 · Cited by 271
Bone homeostasis in growth hormone receptor–null mice is restored by IGF-I but independent of Stat5
Sims, N. A., Clément-Lacroix, P., Da Ponte, F., Bouali, Y., Binart, N., Moriggl, R., Goffin, V., Coschigano, K., Gaillard-Kelly, M., Kopchick, J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10753 · Cited by 251
Self-citationAn Expression Signature Classifies Chemotherapy-Resistant Pediatric Osteosarcoma
Mintz, M. B., Sowers, R., Brown, K. M., Hilmer, S. C., Mazza, B., Huvos, A. G., Meyers, P. A., LaFleur, B., McDonough, W. S., Henry, M. M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2463 · Cited by 215
Terminal osteoblast differentiation, mediated by runx2 and p27 KIP1, is disrupted in osteosarcoma
Thomas, D. M., Johnson, S. A., Sims, N. A., Trivett, M. K., Slavin, J. L., Rubin, B. P., Waring, P., McArthur, G. A., Walkley, C. R., Holloway, A. J., et al. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200409187 · Cited by 208
Self-citationFrequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers
Taniguchi, H., Yamamoto, H., Hirata, T., Miyamoto, N., Oki, M., Nosho, K., Adachi, Y., Endo, T., Imai, K., & Shinomura, Y. (2005) · Oncogene · doi:10.1038/sj.onc.1208910 · Cited by 203
Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors
Chen, W. Y., Zeng, X., Carter, M. G., Morrell, C. N., Chiu Yen, R.-W., Esteller, M., Watkins, D. N., Herman, J. G., Mankowski, J. L., & Baylin, S. B. (2003) · Nature Genetics · doi:10.1038/ng1077 · Cited by 201
Kahler, R. A., & Westendorf, J. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211443200 · Cited by 194
Mancini, D. N., Rodenhiser, D. I., Ainsworth, P. J., O'Malley, F. P., Singh, S. M., Xing, W., & Archer, T. K. (1998) · Oncogene · doi:10.1038/sj.onc.1201630 · Cited by 190
Urakami, S., Shiina, H., Enokida, H., Kawakami, T., Tokizane, T., Ogishima, T., Tanaka, Y., Li, L.-C., Ribeiro-Filho, L. A., Terashima, M., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1344 · Cited by 189
Roles of Wnt signalling in bone growth, remodelling, skeletal disorders and fracture repair
Macsai, C. E., Foster, B. K., & Xian, C. J. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21342 · Cited by 187
Ai, L., Tao, Q., Zhong, S., Fields, C. R., Kim, W.-J., Lee, M. W., Cui, Y., Brown, K. D., & Robertson, K. D. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi379 · Cited by 176
Haydon, R. C., Deyrup, A., Ishikawa, A., Heck, R., Jiang, W., Zhou, L., Feng, T., King, D., Cheng, H., Breyer, B., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10719 · Cited by 171
Szabó, P. E., & Mann, J. R. (1995) · Genes & Development · doi:10.1101/gad.9.24.3097 · Cited by 165
Jolette, J., Wilker, C. E., Smith, S. Y., Doyle, N. E., Hardisty, J. F., Metcalfe, A. J., Marriott, T. B., Fox, J., & Wells, D. S. (2006) · Toxicologic Pathology · doi:10.1080/01926230601072301 · Cited by 144
Morgan, T., Atkins, G. J., Trivett, M. K., Johnson, S. A. S., Kansara, M., Schlicht, S., Slavin, J., Simmons, P. J., Dickinson, I. C., Powell, G., et al. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62959-8 · Cited by 136
Self-citationOsteosarcoma and Teriparatide?
Harper, K. D., Krege, J. H., Marcus, R., & Mitlak, B. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.061111 · Cited by 120
Schmidt, I. U., Dobnig, H., & Turner, R. T. (1995) · Endocrinology · doi:10.1210/endo.136.11.7588250 · Cited by 119
The Genetics of Low-Density Lipoprotein Receptor-Related Protein 5 in Bone: A Story of Extremes
Balemans, W., & Hul, W. V. (2007) · Endocrinology · doi:10.1210/en.2006-1352 · Cited by 116
Wnt Pathway Inhibitors Are Strongly Down-Regulated in Pituitary Tumors
Elston, M. S., Gill, A. J., Conaglen, J. V., Clarkson, A., Shaw, J. M., Law, A. J. J., Cook, R., Little, N., Clifton-Bligh, R. J., Robinson, B. G., et al. (2007) · Endocrinology · doi:10.1210/en.2007-0542 · Cited by 115
Cytoplasmic and/or nuclear staining of beta-catenin is associated with lung metastasis
Iwaya, K., Ogawa, H., Kuroda, M., Izumi, M., Ishida, T., & Mukai, K. (2003) · Clinical & Experimental Metastasis · doi:10.1023/a:1025821229013 · Cited by 107
Vaes, B. L. T., Dechering, K. J., Feijen, A., Hendriks, J. M. A., Lefèvre, C. M., Mummery, C. L., Olijve, W., van Zoelen, E. J. J., & Steegenga, W. T. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.12.2106 · Cited by 101
An In vivo Tumor Model Exploiting Metabolic Response as a Biomarker for Targeted Drug Development
Cullinane, C. M., Dorow, D. S., Kansara, M., Conus, N. M., Binns, D., Hicks, R. J., Ashman, L. K., McArthur, G. A., & Thomas, D. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2285 · Cited by 79
Self-citationSadiković, B., Yoshimoto, M., Al-Romaih, K. I., Maire, G., Zieleńska, M., & Squire, J. A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002834 · Cited by 77
Bodine, P. V. N., Seestaller‐Wehr, L., Kharode, Y. P., Bex, F. J., & Komm, B. S. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20834 · Cited by 74
Sims, N. A., Brennan, K., Spaliviero, J. A., Handelsman, D. J., & Seibel, M. J. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00311.2005 · Cited by 74
Self-citationEpigenetic modifications in osteogenic differentiation and transformation
Thomas, D. M., & Kansara, M. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20850 · Cited by 70
Self-citationFunctional analysis of CpG methylation in the BRCA1 promoter region
Mancini, D. N., Butcher, D. T., Robinson, D. P., Archer, T., & Rodenhiser, D. I. (2001) · Oncogene · doi:10.1038/sj.onc.1204697 · Cited by 65
Coussens, A. K., Hughes, I. P., Wilkinson, C. R., Morris, C. P., Anderson, P. J., Powell, B. C., & van Daal, A. (2008) · Differentiation · doi:10.1111/j.1432-0436.2007.00244.x · Cited by 61
WIF1, an inhibitor of the Wnt pathway, is rearranged in salivary gland tumors
Queimado, L., Lopes, C. S., & Reis, A. (2006) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20402 · Cited by 58
Sex and tissue-specific differences in low-dose radiation-induced oncogenic signaling
Besplug, J., Burke, P., Ponton, A., Filkowski, J. N., Titov, V., Kovalchuk, I., & Kovalchuk, O. (2005) · International Journal of Radiation Biology · doi:10.1080/09553000500103512 · Cited by 21
Cited by
Osteoporosis: now and the future
Rachner, T. D., Khosla, S., & Hofbauer, L. C. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62349-5 · Cited by 2,696
WNT signaling in bone homeostasis and disease: From human mutations to treatments
Baron, R., & Kneissel, M. (2013) · Nature Medicine · doi:10.1038/nm.3074 · Cited by 2,093
WNT signalling pathways as therapeutic targets in cancer
Anastas, J. N., & Moon, R. T. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3419 · Cited by 1,911
Translational biology of osteosarcoma
Kansara, M., Teng, M. W., Smyth, M. J., & Thomas, D. M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3838 · Cited by 1,294
Self-citationSecreted and transmembrane wnt inhibitors and activators
Cruciat, C.-M., & Niehrs, C. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a015081 · Cited by 646
Metadata
- Authors
- Kansara, M., Tsang, M., Kodjabachian, L., Sims, N. A., Trivett, M. K., Ehrich, M., Dobrovic, A., Slavin, J., Choong, P. F. M., Simmons, P. J., Dawid, I. B., & Thomas, D. M.
- Venue
- Journal of Clinical Investigation
- Published
- 2009-04-01
- Volume
- 119
- Issue
- 4
- Pages
- 837-851
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2008432341
- Cited by
- 272
- References
- 65
- FWCI
- 10.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.